Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn

Index by author

July 01, 1993; Volume 21,Issue 4
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Abeysinghe, R D

    1. You have access
      Intravenous infusion pharmacokinetics of desferrioxamine in thalassaemic patients.
      P Lee, N Mohammed, L Marshall, R D Abeysinghe, R C Hider, J B Porter and S Singh
      Drug Metabolism and Disposition July 1993, 21 (4) 640-644;
  2. Abiteboul, M

    1. You have access
      In vitro irreversible binding of ketoprofen glucuronide to plasma proteins.
      N Dubois, F Lapicque, M H Maurice, M Pritchard, S Fournel-Gigleux, J Magdalou, M Abiteboul, G Siest and P Netter
      Drug Metabolism and Disposition July 1993, 21 (4) 617-623;
  3. Adusumalli, V E

    1. You have access
      Isolation and identification of 3-carbamoyloxy-2-phenylpropionic acid as a major human urinary metabolite of felbamate.
      V E Adusumalli, Y M Choi, L A Romanyshyn, R E Sparadoski, J K Wichmann, K K Wong, N Kucharczyk and R D Sofia
      Drug Metabolism and Disposition July 1993, 21 (4) 710-716;
  4. Ahluwalia, G

    1. You have access
      Characterization of 2',3'-dideoxycytidine diphosphocholine and 2',3'-dideoxycytidine diphosphoethanolamine. Prominent phosphodiester metabolites of the anti-HIV nucleoside 2',3'-dideoxycytidine.
      Z Hao, E E Stowe, G Ahluwalia, D C Baker, A K Hebbler, C Chisena, S M Musser, J A Kelley, C F Perno and D G Johns
      Drug Metabolism and Disposition July 1993, 21 (4) 738-744;
  5. Anders, M W

    1. You have access
      Gas-uptake pharmacokinetics and biotransformation of 1,1-dichloro-1-fluoroethane (HCFC-141b).
      G D Loizou and M W Anders
      Drug Metabolism and Disposition July 1993, 21 (4) 634-639;
  6. Arison, B H

    1. You have access
      Evidence for a 1,2-hydride shift in the microsomal metabolism of the heterocycle L-158,338, a nonpeptide angiotensin II receptor antagonist.
      R A Stearns, R R Miller, B H Arison, A Rosegay, J L Smith, N B Mantlo and S H Chiu
      Drug Metabolism and Disposition July 1993, 21 (4) 670-676;

B

  1. Baillie, T A

    1. You have access
      Stereochemical studies on the beta-oxidation of valproic acid in isolated rat hepatocytes.
      M A Shirley, P Hu and T A Baillie
      Drug Metabolism and Disposition July 1993, 21 (4) 580-586;
  2. Baker, D C

    1. You have access
      Characterization of 2',3'-dideoxycytidine diphosphocholine and 2',3'-dideoxycytidine diphosphoethanolamine. Prominent phosphodiester metabolites of the anti-HIV nucleoside 2',3'-dideoxycytidine.
      Z Hao, E E Stowe, G Ahluwalia, D C Baker, A K Hebbler, C Chisena, S M Musser, J A Kelley, C F Perno and D G Johns
      Drug Metabolism and Disposition July 1993, 21 (4) 738-744;
  3. Balani, S K

    1. You have access
      Biotransformation of 5-chloro-3-phenylthioindole-2-carboxamide (L-734,005) in rhesus monkeys and rat liver microsomes to a potent HIV-1 reverse transcriptase inhibitor.
      S K Balani, M E Goldman, L R Kauffman, S L Varga, J A O'Brien, S J Smith, T V Olah, H G Ramjit, T W Schorn and S M Pitzenberger
      Drug Metabolism and Disposition July 1993, 21 (4) 598-604;
  4. Benet, L Z

    1. You have access
      Cyclosporine metabolism by rat liver microsomes. Evidence for involvement of enzyme(s) other than cytochromes P-450 3A.
      T Prueksaritanont, M A Correia, A E Rettie, D C Swinney, P E Thomas and L Z Benet
      Drug Metabolism and Disposition July 1993, 21 (4) 730-737;
  5. Benincosa, L J

    1. You have access
      Inhibition of sulfate transport in rat kidney membrane vesicle preparations by nonsteroidal antiinflammatory drugs.
      L J Benincosa and M E Morris
      Drug Metabolism and Disposition July 1993, 21 (4) 750-752;
  6. Blackburn, R K

    1. You have access
      Application of an immobilized digestive enzyme assay to measure chemical and enzymatic hydrolysis of the cyclic peptide antibiotic lysobactin.
      R K Blackburn and R B Van Breemen
      Drug Metabolism and Disposition July 1993, 21 (4) 573-579;
  7. Brett, C M

    1. You have access
      Chemical, enzymatic, and human enantioselective S-oxygenation of cimetidine.
      J R Cashman, S B Park, Z C Yang, C B Washington, D Y Gomez, K M Giacomini and C M Brett
      Drug Metabolism and Disposition July 1993, 21 (4) 587-597;

C

  1. Cai, Y

    1. You have access
      Redox cycling and hepatotoxicity of diquat in aging male Fischer 344 rats.
      L E Rikans, Y Cai, S D Kosanke and P S Venkataraman
      Drug Metabolism and Disposition July 1993, 21 (4) 605-610;
  2. Cashman, J R

    1. You have access
      Chemical, enzymatic, and human enantioselective S-oxygenation of cimetidine.
      J R Cashman, S B Park, Z C Yang, C B Washington, D Y Gomez, K M Giacomini and C M Brett
      Drug Metabolism and Disposition July 1993, 21 (4) 587-597;
  3. Chiba, K

    1. You have access
      The kinetic characterization of S-mephenytoin 4-hydroxylase (P-450IICMP) activity in human liver samples obtained as surgical waste from Japanese patients.
      K Chiba, K Kobayashi, M Tani, K Manabe and T Ishizaki
      Drug Metabolism and Disposition July 1993, 21 (4) 747-749;
  4. Chisena, C

    1. You have access
      Characterization of 2',3'-dideoxycytidine diphosphocholine and 2',3'-dideoxycytidine diphosphoethanolamine. Prominent phosphodiester metabolites of the anti-HIV nucleoside 2',3'-dideoxycytidine.
      Z Hao, E E Stowe, G Ahluwalia, D C Baker, A K Hebbler, C Chisena, S M Musser, J A Kelley, C F Perno and D G Johns
      Drug Metabolism and Disposition July 1993, 21 (4) 738-744;
  5. Chiu, S H

    1. You have access
      Evidence for a 1,2-hydride shift in the microsomal metabolism of the heterocycle L-158,338, a nonpeptide angiotensin II receptor antagonist.
      R A Stearns, R R Miller, B H Arison, A Rosegay, J L Smith, N B Mantlo and S H Chiu
      Drug Metabolism and Disposition July 1993, 21 (4) 670-676;
  6. Choi, Y M

    1. You have access
      Isolation and identification of 3-carbamoyloxy-2-phenylpropionic acid as a major human urinary metabolite of felbamate.
      V E Adusumalli, Y M Choi, L A Romanyshyn, R E Sparadoski, J K Wichmann, K K Wong, N Kucharczyk and R D Sofia
      Drug Metabolism and Disposition July 1993, 21 (4) 710-716;
  7. Chow, F S

    1. You have access
      Disposition of tacrolimus (FK 506) in rabbits. Role of red blood cell binding in hepatic clearance.
      W Piekoszewski, F S Chow and W J Jusko
      Drug Metabolism and Disposition July 1993, 21 (4) 690-698;
  8. Cook, C E

    1. You have access
      Pharmacokinetics of methamphetamine self-administered to human subjects by smoking S-(+)-methamphetamine hydrochloride.
      C E Cook, A R Jeffcoat, J M Hill, D E Pugh, P K Patetta, B M Sadler, W R White and M Perez-Reyes
      Drug Metabolism and Disposition July 1993, 21 (4) 717-723;
  9. Correia, M A

    1. You have access
      Cyclosporine metabolism by rat liver microsomes. Evidence for involvement of enzyme(s) other than cytochromes P-450 3A.
      T Prueksaritanont, M A Correia, A E Rettie, D C Swinney, P E Thomas and L Z Benet
      Drug Metabolism and Disposition July 1993, 21 (4) 730-737;
  10. Coulombe, R A

    1. You have access
      Pharmacokinetics of the antiviral agent carbocyclic 3-deazaadenosine.
      R A Coulombe, J M Huie, R P Sharma and J W Huggins
      Drug Metabolism and Disposition July 1993, 21 (4) 555-559;

D

  1. Dain, J G

    1. You have access
      Biotransformation of fluvastatin sodium in humans.
      J G Dain, E Fu, J Gorski, J Nicoletti and T J Scallen
      Drug Metabolism and Disposition July 1993, 21 (4) 567-572;
  2. Dilea, C

    1. You have access
      Comparative kinetics of sematilide in four species.
      P H Hinderling, C Dilea, T Koziol and G Millington
      Drug Metabolism and Disposition July 1993, 21 (4) 662-669;
  3. Dogterom, P

    1. You have access
      Development of a simple incubation system for metabolism studies with precision-cut liver slices.
      P Dogterom
      Drug Metabolism and Disposition July 1993, 21 (4) 699-704;
    2. You have access
      A species comparison of tolbutamide metabolism in precision-cut liver slices from rats and dogs. Qualitative and quantitative sex differences.
      P Dogterom and J Rothuizen
      Drug Metabolism and Disposition July 1993, 21 (4) 705-709;
  4. Donahue, B S

    1. You have access
      Pretranslational induction of CYP4A subfamily gene products in diabetic rats and reversal by oral vanadate treatment.
      N L Ferguson, B S Donahue, K A Tenney and E T Morgan
      Drug Metabolism and Disposition July 1993, 21 (4) 745-746;
  5. Dubois, N

    1. You have access
      In vitro irreversible binding of ketoprofen glucuronide to plasma proteins.
      N Dubois, F Lapicque, M H Maurice, M Pritchard, S Fournel-Gigleux, J Magdalou, M Abiteboul, G Siest and P Netter
      Drug Metabolism and Disposition July 1993, 21 (4) 617-623;

F

  1. Feil, V J

    1. You have access
      Metabolism and disposition of ractopamine hydrochloride by turkey poults.
      D J Smith, V J Feil, J K Huwe and G D Paulson
      Drug Metabolism and Disposition July 1993, 21 (4) 624-633;
  2. Ferguson, N L

    1. You have access
      Pretranslational induction of CYP4A subfamily gene products in diabetic rats and reversal by oral vanadate treatment.
      N L Ferguson, B S Donahue, K A Tenney and E T Morgan
      Drug Metabolism and Disposition July 1993, 21 (4) 745-746;
  3. Fournel-Gigleux, S

    1. You have access
      In vitro irreversible binding of ketoprofen glucuronide to plasma proteins.
      N Dubois, F Lapicque, M H Maurice, M Pritchard, S Fournel-Gigleux, J Magdalou, M Abiteboul, G Siest and P Netter
      Drug Metabolism and Disposition July 1993, 21 (4) 617-623;
  4. Fu, E

    1. You have access
      Biotransformation of fluvastatin sodium in humans.
      J G Dain, E Fu, J Gorski, J Nicoletti and T J Scallen
      Drug Metabolism and Disposition July 1993, 21 (4) 567-572;

G

  1. Gachon, F

    1. You have access
      Biodistribution and metabolism of orally administered mitozolomide in mice.
      F Gachon, P Labarre, D Godeneche, M F Moreau, J Papon, J C Madelmont, A Veyre and G Gaillard
      Drug Metabolism and Disposition July 1993, 21 (4) 560-566;
  2. Gaillard, G

    1. You have access
      Biodistribution and metabolism of orally administered mitozolomide in mice.
      F Gachon, P Labarre, D Godeneche, M F Moreau, J Papon, J C Madelmont, A Veyre and G Gaillard
      Drug Metabolism and Disposition July 1993, 21 (4) 560-566;
  3. Gelboin, H V

    1. You have access
      Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. I. Cytochrome P-450-catalyzed N-demethylation and 4-hydroxylation.
      C Mani, H V Gelboin, S S Park, R Pearce, A Parkinson and D Kupfer
      Drug Metabolism and Disposition July 1993, 21 (4) 645-656;
  4. Giacomini, K M

    1. You have access
      Chemical, enzymatic, and human enantioselective S-oxygenation of cimetidine.
      J R Cashman, S B Park, Z C Yang, C B Washington, D Y Gomez, K M Giacomini and C M Brett
      Drug Metabolism and Disposition July 1993, 21 (4) 587-597;
  5. Godeneche, D

    1. You have access
      Biodistribution and metabolism of orally administered mitozolomide in mice.
      F Gachon, P Labarre, D Godeneche, M F Moreau, J Papon, J C Madelmont, A Veyre and G Gaillard
      Drug Metabolism and Disposition July 1993, 21 (4) 560-566;
  6. Goldman, M E

    1. You have access
      Biotransformation of 5-chloro-3-phenylthioindole-2-carboxamide (L-734,005) in rhesus monkeys and rat liver microsomes to a potent HIV-1 reverse transcriptase inhibitor.
      S K Balani, M E Goldman, L R Kauffman, S L Varga, J A O'Brien, S J Smith, T V Olah, H G Ramjit, T W Schorn and S M Pitzenberger
      Drug Metabolism and Disposition July 1993, 21 (4) 598-604;
  7. Gomez, D Y

    1. You have access
      Chemical, enzymatic, and human enantioselective S-oxygenation of cimetidine.
      J R Cashman, S B Park, Z C Yang, C B Washington, D Y Gomez, K M Giacomini and C M Brett
      Drug Metabolism and Disposition July 1993, 21 (4) 587-597;
  8. Gorski, J

    1. You have access
      Biotransformation of fluvastatin sodium in humans.
      J G Dain, E Fu, J Gorski, J Nicoletti and T J Scallen
      Drug Metabolism and Disposition July 1993, 21 (4) 567-572;

H

  1. Hao, Z

    1. You have access
      Characterization of 2',3'-dideoxycytidine diphosphocholine and 2',3'-dideoxycytidine diphosphoethanolamine. Prominent phosphodiester metabolites of the anti-HIV nucleoside 2',3'-dideoxycytidine.
      Z Hao, E E Stowe, G Ahluwalia, D C Baker, A K Hebbler, C Chisena, S M Musser, J A Kelley, C F Perno and D G Johns
      Drug Metabolism and Disposition July 1993, 21 (4) 738-744;
  2. Hasegawa, T

    1. You have access
      The disposition and renal handling of enprofylline in endotoxemic rats by bacterial lipopolysaccharide (LPS).
      M Nadai, T Hasegawa, K Kato, L Wang, T Nabeshima and N Kato
      Drug Metabolism and Disposition July 1993, 21 (4) 611-616;
  3. Hebbler, A K

    1. You have access
      Characterization of 2',3'-dideoxycytidine diphosphocholine and 2',3'-dideoxycytidine diphosphoethanolamine. Prominent phosphodiester metabolites of the anti-HIV nucleoside 2',3'-dideoxycytidine.
      Z Hao, E E Stowe, G Ahluwalia, D C Baker, A K Hebbler, C Chisena, S M Musser, J A Kelley, C F Perno and D G Johns
      Drug Metabolism and Disposition July 1993, 21 (4) 738-744;
  4. Hider, R C

    1. You have access
      Intravenous infusion pharmacokinetics of desferrioxamine in thalassaemic patients.
      P Lee, N Mohammed, L Marshall, R D Abeysinghe, R C Hider, J B Porter and S Singh
      Drug Metabolism and Disposition July 1993, 21 (4) 640-644;
  5. Hill, J M

    1. You have access
      Pharmacokinetics of methamphetamine self-administered to human subjects by smoking S-(+)-methamphetamine hydrochloride.
      C E Cook, A R Jeffcoat, J M Hill, D E Pugh, P K Patetta, B M Sadler, W R White and M Perez-Reyes
      Drug Metabolism and Disposition July 1993, 21 (4) 717-723;
  6. Hinderling, P H

    1. You have access
      Comparative kinetics of sematilide in four species.
      P H Hinderling, C Dilea, T Koziol and G Millington
      Drug Metabolism and Disposition July 1993, 21 (4) 662-669;
  7. Hodgson, E

    1. You have access
      Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. II. Flavin-containing monooxygenase-mediated N-oxidation.
      C Mani, E Hodgson and D Kupfer
      Drug Metabolism and Disposition July 1993, 21 (4) 657-661;
  8. Hoyer, G A

    1. You have access
      Biotransformation of the antidepressant DL-rolipram. I. Isolation and identification of metabolites from rat, monkey, and human urine.
      W Krause, G Kühne, U Jakobs and G A Hoyer
      Drug Metabolism and Disposition July 1993, 21 (4) 682-689;
  9. Hu, P

    1. You have access
      Stereochemical studies on the beta-oxidation of valproic acid in isolated rat hepatocytes.
      M A Shirley, P Hu and T A Baillie
      Drug Metabolism and Disposition July 1993, 21 (4) 580-586;
  10. Huggins, J W

    1. You have access
      Pharmacokinetics of the antiviral agent carbocyclic 3-deazaadenosine.
      R A Coulombe, J M Huie, R P Sharma and J W Huggins
      Drug Metabolism and Disposition July 1993, 21 (4) 555-559;
  11. Huie, J M

    1. You have access
      Pharmacokinetics of the antiviral agent carbocyclic 3-deazaadenosine.
      R A Coulombe, J M Huie, R P Sharma and J W Huggins
      Drug Metabolism and Disposition July 1993, 21 (4) 555-559;
  12. Huwe, J K

    1. You have access
      Metabolism and disposition of ractopamine hydrochloride by turkey poults.
      D J Smith, V J Feil, J K Huwe and G D Paulson
      Drug Metabolism and Disposition July 1993, 21 (4) 624-633;

I

  1. Ishizaki, T

    1. You have access
      The kinetic characterization of S-mephenytoin 4-hydroxylase (P-450IICMP) activity in human liver samples obtained as surgical waste from Japanese patients.
      K Chiba, K Kobayashi, M Tani, K Manabe and T Ishizaki
      Drug Metabolism and Disposition July 1993, 21 (4) 747-749;

J

  1. Jakobs, U

    1. You have access
      Biotransformation of the antidepressant DL-rolipram. I. Isolation and identification of metabolites from rat, monkey, and human urine.
      W Krause, G Kühne, U Jakobs and G A Hoyer
      Drug Metabolism and Disposition July 1993, 21 (4) 682-689;
  2. Jeffcoat, A R

    1. You have access
      Pharmacokinetics of methamphetamine self-administered to human subjects by smoking S-(+)-methamphetamine hydrochloride.
      C E Cook, A R Jeffcoat, J M Hill, D E Pugh, P K Patetta, B M Sadler, W R White and M Perez-Reyes
      Drug Metabolism and Disposition July 1993, 21 (4) 717-723;
  3. Johns, D G

    1. You have access
      Characterization of 2',3'-dideoxycytidine diphosphocholine and 2',3'-dideoxycytidine diphosphoethanolamine. Prominent phosphodiester metabolites of the anti-HIV nucleoside 2',3'-dideoxycytidine.
      Z Hao, E E Stowe, G Ahluwalia, D C Baker, A K Hebbler, C Chisena, S M Musser, J A Kelley, C F Perno and D G Johns
      Drug Metabolism and Disposition July 1993, 21 (4) 738-744;
  4. Jusko, W J

    1. You have access
      Disposition of tacrolimus (FK 506) in rabbits. Role of red blood cell binding in hepatic clearance.
      W Piekoszewski, F S Chow and W J Jusko
      Drug Metabolism and Disposition July 1993, 21 (4) 690-698;

K

  1. Kato, K

    1. You have access
      The disposition and renal handling of enprofylline in endotoxemic rats by bacterial lipopolysaccharide (LPS).
      M Nadai, T Hasegawa, K Kato, L Wang, T Nabeshima and N Kato
      Drug Metabolism and Disposition July 1993, 21 (4) 611-616;
  2. Kato, N

    1. You have access
      The disposition and renal handling of enprofylline in endotoxemic rats by bacterial lipopolysaccharide (LPS).
      M Nadai, T Hasegawa, K Kato, L Wang, T Nabeshima and N Kato
      Drug Metabolism and Disposition July 1993, 21 (4) 611-616;
  3. Kauffman, L R

    1. You have access
      Biotransformation of 5-chloro-3-phenylthioindole-2-carboxamide (L-734,005) in rhesus monkeys and rat liver microsomes to a potent HIV-1 reverse transcriptase inhibitor.
      S K Balani, M E Goldman, L R Kauffman, S L Varga, J A O'Brien, S J Smith, T V Olah, H G Ramjit, T W Schorn and S M Pitzenberger
      Drug Metabolism and Disposition July 1993, 21 (4) 598-604;
  4. Kelley, J A

    1. You have access
      Characterization of 2',3'-dideoxycytidine diphosphocholine and 2',3'-dideoxycytidine diphosphoethanolamine. Prominent phosphodiester metabolites of the anti-HIV nucleoside 2',3'-dideoxycytidine.
      Z Hao, E E Stowe, G Ahluwalia, D C Baker, A K Hebbler, C Chisena, S M Musser, J A Kelley, C F Perno and D G Johns
      Drug Metabolism and Disposition July 1993, 21 (4) 738-744;
  5. Kimura, T

    1. You have access
      Pharmacokinetics of zenarestat, an aldose reductase inhibitor, in male and female diabetic rats.
      Y Tanaka, T Sawamoto, A Suzuki and T Kimura
      Drug Metabolism and Disposition July 1993, 21 (4) 677-681;
  6. Kobayashi, K

    1. You have access
      The kinetic characterization of S-mephenytoin 4-hydroxylase (P-450IICMP) activity in human liver samples obtained as surgical waste from Japanese patients.
      K Chiba, K Kobayashi, M Tani, K Manabe and T Ishizaki
      Drug Metabolism and Disposition July 1993, 21 (4) 747-749;
  7. Kosanke, S D

    1. You have access
      Redox cycling and hepatotoxicity of diquat in aging male Fischer 344 rats.
      L E Rikans, Y Cai, S D Kosanke and P S Venkataraman
      Drug Metabolism and Disposition July 1993, 21 (4) 605-610;
  8. Koziol, T

    1. You have access
      Comparative kinetics of sematilide in four species.
      P H Hinderling, C Dilea, T Koziol and G Millington
      Drug Metabolism and Disposition July 1993, 21 (4) 662-669;
  9. Krause, W

    1. You have access
      Biotransformation of the antidepressant DL-rolipram. I. Isolation and identification of metabolites from rat, monkey, and human urine.
      W Krause, G Kühne, U Jakobs and G A Hoyer
      Drug Metabolism and Disposition July 1993, 21 (4) 682-689;
  10. Kucharczyk, N

    1. You have access
      Isolation and identification of 3-carbamoyloxy-2-phenylpropionic acid as a major human urinary metabolite of felbamate.
      V E Adusumalli, Y M Choi, L A Romanyshyn, R E Sparadoski, J K Wichmann, K K Wong, N Kucharczyk and R D Sofia
      Drug Metabolism and Disposition July 1993, 21 (4) 710-716;
  11. Kühne, G

    1. You have access
      Biotransformation of the antidepressant DL-rolipram. I. Isolation and identification of metabolites from rat, monkey, and human urine.
      W Krause, G Kühne, U Jakobs and G A Hoyer
      Drug Metabolism and Disposition July 1993, 21 (4) 682-689;
  12. Kupfer, D

    1. You have access
      Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. I. Cytochrome P-450-catalyzed N-demethylation and 4-hydroxylation.
      C Mani, H V Gelboin, S S Park, R Pearce, A Parkinson and D Kupfer
      Drug Metabolism and Disposition July 1993, 21 (4) 645-656;
    2. You have access
      Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. II. Flavin-containing monooxygenase-mediated N-oxidation.
      C Mani, E Hodgson and D Kupfer
      Drug Metabolism and Disposition July 1993, 21 (4) 657-661;

L

  1. Labarre, P

    1. You have access
      Biodistribution and metabolism of orally administered mitozolomide in mice.
      F Gachon, P Labarre, D Godeneche, M F Moreau, J Papon, J C Madelmont, A Veyre and G Gaillard
      Drug Metabolism and Disposition July 1993, 21 (4) 560-566;
  2. Lapicque, F

    1. You have access
      In vitro irreversible binding of ketoprofen glucuronide to plasma proteins.
      N Dubois, F Lapicque, M H Maurice, M Pritchard, S Fournel-Gigleux, J Magdalou, M Abiteboul, G Siest and P Netter
      Drug Metabolism and Disposition July 1993, 21 (4) 617-623;
  3. Lee, P

    1. You have access
      Intravenous infusion pharmacokinetics of desferrioxamine in thalassaemic patients.
      P Lee, N Mohammed, L Marshall, R D Abeysinghe, R C Hider, J B Porter and S Singh
      Drug Metabolism and Disposition July 1993, 21 (4) 640-644;
  4. Loizou, G D

    1. You have access
      Gas-uptake pharmacokinetics and biotransformation of 1,1-dichloro-1-fluoroethane (HCFC-141b).
      G D Loizou and M W Anders
      Drug Metabolism and Disposition July 1993, 21 (4) 634-639;

M

  1. Madelmont, J C

    1. You have access
      Biodistribution and metabolism of orally administered mitozolomide in mice.
      F Gachon, P Labarre, D Godeneche, M F Moreau, J Papon, J C Madelmont, A Veyre and G Gaillard
      Drug Metabolism and Disposition July 1993, 21 (4) 560-566;
  2. Magdalou, J

    1. You have access
      In vitro irreversible binding of ketoprofen glucuronide to plasma proteins.
      N Dubois, F Lapicque, M H Maurice, M Pritchard, S Fournel-Gigleux, J Magdalou, M Abiteboul, G Siest and P Netter
      Drug Metabolism and Disposition July 1993, 21 (4) 617-623;
  3. Manabe, K

    1. You have access
      The kinetic characterization of S-mephenytoin 4-hydroxylase (P-450IICMP) activity in human liver samples obtained as surgical waste from Japanese patients.
      K Chiba, K Kobayashi, M Tani, K Manabe and T Ishizaki
      Drug Metabolism and Disposition July 1993, 21 (4) 747-749;
  4. Mani, C

    1. You have access
      Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. I. Cytochrome P-450-catalyzed N-demethylation and 4-hydroxylation.
      C Mani, H V Gelboin, S S Park, R Pearce, A Parkinson and D Kupfer
      Drug Metabolism and Disposition July 1993, 21 (4) 645-656;
    2. You have access
      Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. II. Flavin-containing monooxygenase-mediated N-oxidation.
      C Mani, E Hodgson and D Kupfer
      Drug Metabolism and Disposition July 1993, 21 (4) 657-661;
  5. Mantlo, N B

    1. You have access
      Evidence for a 1,2-hydride shift in the microsomal metabolism of the heterocycle L-158,338, a nonpeptide angiotensin II receptor antagonist.
      R A Stearns, R R Miller, B H Arison, A Rosegay, J L Smith, N B Mantlo and S H Chiu
      Drug Metabolism and Disposition July 1993, 21 (4) 670-676;
  6. Marshall, L

    1. You have access
      Intravenous infusion pharmacokinetics of desferrioxamine in thalassaemic patients.
      P Lee, N Mohammed, L Marshall, R D Abeysinghe, R C Hider, J B Porter and S Singh
      Drug Metabolism and Disposition July 1993, 21 (4) 640-644;
  7. Maurice, M H

    1. You have access
      In vitro irreversible binding of ketoprofen glucuronide to plasma proteins.
      N Dubois, F Lapicque, M H Maurice, M Pritchard, S Fournel-Gigleux, J Magdalou, M Abiteboul, G Siest and P Netter
      Drug Metabolism and Disposition July 1993, 21 (4) 617-623;
  8. Miller, R R

    1. You have access
      Evidence for a 1,2-hydride shift in the microsomal metabolism of the heterocycle L-158,338, a nonpeptide angiotensin II receptor antagonist.
      R A Stearns, R R Miller, B H Arison, A Rosegay, J L Smith, N B Mantlo and S H Chiu
      Drug Metabolism and Disposition July 1993, 21 (4) 670-676;
  9. Millington, G

    1. You have access
      Comparative kinetics of sematilide in four species.
      P H Hinderling, C Dilea, T Koziol and G Millington
      Drug Metabolism and Disposition July 1993, 21 (4) 662-669;
  10. Mohammed, N

    1. You have access
      Intravenous infusion pharmacokinetics of desferrioxamine in thalassaemic patients.
      P Lee, N Mohammed, L Marshall, R D Abeysinghe, R C Hider, J B Porter and S Singh
      Drug Metabolism and Disposition July 1993, 21 (4) 640-644;
  11. Moreau, M F

    1. You have access
      Biodistribution and metabolism of orally administered mitozolomide in mice.
      F Gachon, P Labarre, D Godeneche, M F Moreau, J Papon, J C Madelmont, A Veyre and G Gaillard
      Drug Metabolism and Disposition July 1993, 21 (4) 560-566;
  12. Morgan, E T

    1. You have access
      Pretranslational induction of CYP4A subfamily gene products in diabetic rats and reversal by oral vanadate treatment.
      N L Ferguson, B S Donahue, K A Tenney and E T Morgan
      Drug Metabolism and Disposition July 1993, 21 (4) 745-746;
  13. Morris, M E

    1. You have access
      Inhibition of sulfate transport in rat kidney membrane vesicle preparations by nonsteroidal antiinflammatory drugs.
      L J Benincosa and M E Morris
      Drug Metabolism and Disposition July 1993, 21 (4) 750-752;
  14. Musser, S M

    1. You have access
      Characterization of 2',3'-dideoxycytidine diphosphocholine and 2',3'-dideoxycytidine diphosphoethanolamine. Prominent phosphodiester metabolites of the anti-HIV nucleoside 2',3'-dideoxycytidine.
      Z Hao, E E Stowe, G Ahluwalia, D C Baker, A K Hebbler, C Chisena, S M Musser, J A Kelley, C F Perno and D G Johns
      Drug Metabolism and Disposition July 1993, 21 (4) 738-744;

N

  1. Nabeshima, T

    1. You have access
      The disposition and renal handling of enprofylline in endotoxemic rats by bacterial lipopolysaccharide (LPS).
      M Nadai, T Hasegawa, K Kato, L Wang, T Nabeshima and N Kato
      Drug Metabolism and Disposition July 1993, 21 (4) 611-616;
  2. Nadai, M

    1. You have access
      The disposition and renal handling of enprofylline in endotoxemic rats by bacterial lipopolysaccharide (LPS).
      M Nadai, T Hasegawa, K Kato, L Wang, T Nabeshima and N Kato
      Drug Metabolism and Disposition July 1993, 21 (4) 611-616;
  3. Netter, P

    1. You have access
      In vitro irreversible binding of ketoprofen glucuronide to plasma proteins.
      N Dubois, F Lapicque, M H Maurice, M Pritchard, S Fournel-Gigleux, J Magdalou, M Abiteboul, G Siest and P Netter
      Drug Metabolism and Disposition July 1993, 21 (4) 617-623;
  4. Nicoletti, J

    1. You have access
      Biotransformation of fluvastatin sodium in humans.
      J G Dain, E Fu, J Gorski, J Nicoletti and T J Scallen
      Drug Metabolism and Disposition July 1993, 21 (4) 567-572;

O

  1. O'Brien, J A

    1. You have access
      Biotransformation of 5-chloro-3-phenylthioindole-2-carboxamide (L-734,005) in rhesus monkeys and rat liver microsomes to a potent HIV-1 reverse transcriptase inhibitor.
      S K Balani, M E Goldman, L R Kauffman, S L Varga, J A O'Brien, S J Smith, T V Olah, H G Ramjit, T W Schorn and S M Pitzenberger
      Drug Metabolism and Disposition July 1993, 21 (4) 598-604;
  2. Olah, T V

    1. You have access
      Biotransformation of 5-chloro-3-phenylthioindole-2-carboxamide (L-734,005) in rhesus monkeys and rat liver microsomes to a potent HIV-1 reverse transcriptase inhibitor.
      S K Balani, M E Goldman, L R Kauffman, S L Varga, J A O'Brien, S J Smith, T V Olah, H G Ramjit, T W Schorn and S M Pitzenberger
      Drug Metabolism and Disposition July 1993, 21 (4) 598-604;

P

  1. Papon, J

    1. You have access
      Biodistribution and metabolism of orally administered mitozolomide in mice.
      F Gachon, P Labarre, D Godeneche, M F Moreau, J Papon, J C Madelmont, A Veyre and G Gaillard
      Drug Metabolism and Disposition July 1993, 21 (4) 560-566;
  2. Park, S B

    1. You have access
      Chemical, enzymatic, and human enantioselective S-oxygenation of cimetidine.
      J R Cashman, S B Park, Z C Yang, C B Washington, D Y Gomez, K M Giacomini and C M Brett
      Drug Metabolism and Disposition July 1993, 21 (4) 587-597;
  3. Park, S S

    1. You have access
      Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. I. Cytochrome P-450-catalyzed N-demethylation and 4-hydroxylation.
      C Mani, H V Gelboin, S S Park, R Pearce, A Parkinson and D Kupfer
      Drug Metabolism and Disposition July 1993, 21 (4) 645-656;
  4. Parkinson, A

    1. You have access
      Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. I. Cytochrome P-450-catalyzed N-demethylation and 4-hydroxylation.
      C Mani, H V Gelboin, S S Park, R Pearce, A Parkinson and D Kupfer
      Drug Metabolism and Disposition July 1993, 21 (4) 645-656;
  5. Patetta, P K

    1. You have access
      Pharmacokinetics of methamphetamine self-administered to human subjects by smoking S-(+)-methamphetamine hydrochloride.
      C E Cook, A R Jeffcoat, J M Hill, D E Pugh, P K Patetta, B M Sadler, W R White and M Perez-Reyes
      Drug Metabolism and Disposition July 1993, 21 (4) 717-723;
  6. Paulson, G D

    1. You have access
      Metabolism and disposition of ractopamine hydrochloride by turkey poults.
      D J Smith, V J Feil, J K Huwe and G D Paulson
      Drug Metabolism and Disposition July 1993, 21 (4) 624-633;
  7. Pearce, R

    1. You have access
      Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. I. Cytochrome P-450-catalyzed N-demethylation and 4-hydroxylation.
      C Mani, H V Gelboin, S S Park, R Pearce, A Parkinson and D Kupfer
      Drug Metabolism and Disposition July 1993, 21 (4) 645-656;
  8. Perez-Reyes, M

    1. You have access
      Pharmacokinetics of methamphetamine self-administered to human subjects by smoking S-(+)-methamphetamine hydrochloride.
      C E Cook, A R Jeffcoat, J M Hill, D E Pugh, P K Patetta, B M Sadler, W R White and M Perez-Reyes
      Drug Metabolism and Disposition July 1993, 21 (4) 717-723;
  9. Perno, C F

    1. You have access
      Characterization of 2',3'-dideoxycytidine diphosphocholine and 2',3'-dideoxycytidine diphosphoethanolamine. Prominent phosphodiester metabolites of the anti-HIV nucleoside 2',3'-dideoxycytidine.
      Z Hao, E E Stowe, G Ahluwalia, D C Baker, A K Hebbler, C Chisena, S M Musser, J A Kelley, C F Perno and D G Johns
      Drug Metabolism and Disposition July 1993, 21 (4) 738-744;
  10. Piekoszewski, W

    1. You have access
      Disposition of tacrolimus (FK 506) in rabbits. Role of red blood cell binding in hepatic clearance.
      W Piekoszewski, F S Chow and W J Jusko
      Drug Metabolism and Disposition July 1993, 21 (4) 690-698;
  11. Pitzenberger, S M

    1. You have access
      Biotransformation of 5-chloro-3-phenylthioindole-2-carboxamide (L-734,005) in rhesus monkeys and rat liver microsomes to a potent HIV-1 reverse transcriptase inhibitor.
      S K Balani, M E Goldman, L R Kauffman, S L Varga, J A O'Brien, S J Smith, T V Olah, H G Ramjit, T W Schorn and S M Pitzenberger
      Drug Metabolism and Disposition July 1993, 21 (4) 598-604;
  12. Porter, J B

    1. You have access
      Intravenous infusion pharmacokinetics of desferrioxamine in thalassaemic patients.
      P Lee, N Mohammed, L Marshall, R D Abeysinghe, R C Hider, J B Porter and S Singh
      Drug Metabolism and Disposition July 1993, 21 (4) 640-644;
  13. Pritchard, M

    1. You have access
      In vitro irreversible binding of ketoprofen glucuronide to plasma proteins.
      N Dubois, F Lapicque, M H Maurice, M Pritchard, S Fournel-Gigleux, J Magdalou, M Abiteboul, G Siest and P Netter
      Drug Metabolism and Disposition July 1993, 21 (4) 617-623;
  14. Prueksaritanont, T

    1. You have access
      Cyclosporine metabolism by rat liver microsomes. Evidence for involvement of enzyme(s) other than cytochromes P-450 3A.
      T Prueksaritanont, M A Correia, A E Rettie, D C Swinney, P E Thomas and L Z Benet
      Drug Metabolism and Disposition July 1993, 21 (4) 730-737;
  15. Pugh, D E

    1. You have access
      Pharmacokinetics of methamphetamine self-administered to human subjects by smoking S-(+)-methamphetamine hydrochloride.
      C E Cook, A R Jeffcoat, J M Hill, D E Pugh, P K Patetta, B M Sadler, W R White and M Perez-Reyes
      Drug Metabolism and Disposition July 1993, 21 (4) 717-723;

R

  1. Ramjit, H G

    1. You have access
      Biotransformation of 5-chloro-3-phenylthioindole-2-carboxamide (L-734,005) in rhesus monkeys and rat liver microsomes to a potent HIV-1 reverse transcriptase inhibitor.
      S K Balani, M E Goldman, L R Kauffman, S L Varga, J A O'Brien, S J Smith, T V Olah, H G Ramjit, T W Schorn and S M Pitzenberger
      Drug Metabolism and Disposition July 1993, 21 (4) 598-604;
  2. Rettie, A E

    1. You have access
      Cyclosporine metabolism by rat liver microsomes. Evidence for involvement of enzyme(s) other than cytochromes P-450 3A.
      T Prueksaritanont, M A Correia, A E Rettie, D C Swinney, P E Thomas and L Z Benet
      Drug Metabolism and Disposition July 1993, 21 (4) 730-737;
  3. Rikans, L E

    1. You have access
      Redox cycling and hepatotoxicity of diquat in aging male Fischer 344 rats.
      L E Rikans, Y Cai, S D Kosanke and P S Venkataraman
      Drug Metabolism and Disposition July 1993, 21 (4) 605-610;
  4. Romanyshyn, L A

    1. You have access
      Isolation and identification of 3-carbamoyloxy-2-phenylpropionic acid as a major human urinary metabolite of felbamate.
      V E Adusumalli, Y M Choi, L A Romanyshyn, R E Sparadoski, J K Wichmann, K K Wong, N Kucharczyk and R D Sofia
      Drug Metabolism and Disposition July 1993, 21 (4) 710-716;
  5. Rosegay, A

    1. You have access
      Evidence for a 1,2-hydride shift in the microsomal metabolism of the heterocycle L-158,338, a nonpeptide angiotensin II receptor antagonist.
      R A Stearns, R R Miller, B H Arison, A Rosegay, J L Smith, N B Mantlo and S H Chiu
      Drug Metabolism and Disposition July 1993, 21 (4) 670-676;
  6. Rothuizen, J

    1. You have access
      A species comparison of tolbutamide metabolism in precision-cut liver slices from rats and dogs. Qualitative and quantitative sex differences.
      P Dogterom and J Rothuizen
      Drug Metabolism and Disposition July 1993, 21 (4) 705-709;

S

  1. Sadler, B M

    1. You have access
      Pharmacokinetics of methamphetamine self-administered to human subjects by smoking S-(+)-methamphetamine hydrochloride.
      C E Cook, A R Jeffcoat, J M Hill, D E Pugh, P K Patetta, B M Sadler, W R White and M Perez-Reyes
      Drug Metabolism and Disposition July 1993, 21 (4) 717-723;
  2. Sawamoto, T

    1. You have access
      Pharmacokinetics of zenarestat, an aldose reductase inhibitor, in male and female diabetic rats.
      Y Tanaka, T Sawamoto, A Suzuki and T Kimura
      Drug Metabolism and Disposition July 1993, 21 (4) 677-681;
  3. Scallen, T J

    1. You have access
      Biotransformation of fluvastatin sodium in humans.
      J G Dain, E Fu, J Gorski, J Nicoletti and T J Scallen
      Drug Metabolism and Disposition July 1993, 21 (4) 567-572;
  4. Schorn, T W

    1. You have access
      Biotransformation of 5-chloro-3-phenylthioindole-2-carboxamide (L-734,005) in rhesus monkeys and rat liver microsomes to a potent HIV-1 reverse transcriptase inhibitor.
      S K Balani, M E Goldman, L R Kauffman, S L Varga, J A O'Brien, S J Smith, T V Olah, H G Ramjit, T W Schorn and S M Pitzenberger
      Drug Metabolism and Disposition July 1993, 21 (4) 598-604;
  5. Sharma, R P

    1. You have access
      Pharmacokinetics of the antiviral agent carbocyclic 3-deazaadenosine.
      R A Coulombe, J M Huie, R P Sharma and J W Huggins
      Drug Metabolism and Disposition July 1993, 21 (4) 555-559;
  6. Shirley, M A

    1. You have access
      Stereochemical studies on the beta-oxidation of valproic acid in isolated rat hepatocytes.
      M A Shirley, P Hu and T A Baillie
      Drug Metabolism and Disposition July 1993, 21 (4) 580-586;
  7. Siest, G

    1. You have access
      In vitro irreversible binding of ketoprofen glucuronide to plasma proteins.
      N Dubois, F Lapicque, M H Maurice, M Pritchard, S Fournel-Gigleux, J Magdalou, M Abiteboul, G Siest and P Netter
      Drug Metabolism and Disposition July 1993, 21 (4) 617-623;
  8. Singh, S

    1. You have access
      Intravenous infusion pharmacokinetics of desferrioxamine in thalassaemic patients.
      P Lee, N Mohammed, L Marshall, R D Abeysinghe, R C Hider, J B Porter and S Singh
      Drug Metabolism and Disposition July 1993, 21 (4) 640-644;
  9. Smith, D J

    1. You have access
      Metabolism and disposition of ractopamine hydrochloride by turkey poults.
      D J Smith, V J Feil, J K Huwe and G D Paulson
      Drug Metabolism and Disposition July 1993, 21 (4) 624-633;
  10. Smith, J L

    1. You have access
      Evidence for a 1,2-hydride shift in the microsomal metabolism of the heterocycle L-158,338, a nonpeptide angiotensin II receptor antagonist.
      R A Stearns, R R Miller, B H Arison, A Rosegay, J L Smith, N B Mantlo and S H Chiu
      Drug Metabolism and Disposition July 1993, 21 (4) 670-676;
  11. Smith, S J

    1. You have access
      Biotransformation of 5-chloro-3-phenylthioindole-2-carboxamide (L-734,005) in rhesus monkeys and rat liver microsomes to a potent HIV-1 reverse transcriptase inhibitor.
      S K Balani, M E Goldman, L R Kauffman, S L Varga, J A O'Brien, S J Smith, T V Olah, H G Ramjit, T W Schorn and S M Pitzenberger
      Drug Metabolism and Disposition July 1993, 21 (4) 598-604;
  12. Sofia, R D

    1. You have access
      Isolation and identification of 3-carbamoyloxy-2-phenylpropionic acid as a major human urinary metabolite of felbamate.
      V E Adusumalli, Y M Choi, L A Romanyshyn, R E Sparadoski, J K Wichmann, K K Wong, N Kucharczyk and R D Sofia
      Drug Metabolism and Disposition July 1993, 21 (4) 710-716;
  13. Soria, I

    1. You have access
      Disposition of (-)carbovir in the in situ perfused rat liver and intestinal vasculature preparations.
      I Soria and C L Zimmerman
      Drug Metabolism and Disposition July 1993, 21 (4) 724-729;
  14. Sparadoski, R E

    1. You have access
      Isolation and identification of 3-carbamoyloxy-2-phenylpropionic acid as a major human urinary metabolite of felbamate.
      V E Adusumalli, Y M Choi, L A Romanyshyn, R E Sparadoski, J K Wichmann, K K Wong, N Kucharczyk and R D Sofia
      Drug Metabolism and Disposition July 1993, 21 (4) 710-716;
  15. Stearns, R A

    1. You have access
      Evidence for a 1,2-hydride shift in the microsomal metabolism of the heterocycle L-158,338, a nonpeptide angiotensin II receptor antagonist.
      R A Stearns, R R Miller, B H Arison, A Rosegay, J L Smith, N B Mantlo and S H Chiu
      Drug Metabolism and Disposition July 1993, 21 (4) 670-676;
  16. Stowe, E E

    1. You have access
      Characterization of 2',3'-dideoxycytidine diphosphocholine and 2',3'-dideoxycytidine diphosphoethanolamine. Prominent phosphodiester metabolites of the anti-HIV nucleoside 2',3'-dideoxycytidine.
      Z Hao, E E Stowe, G Ahluwalia, D C Baker, A K Hebbler, C Chisena, S M Musser, J A Kelley, C F Perno and D G Johns
      Drug Metabolism and Disposition July 1993, 21 (4) 738-744;
  17. Suzuki, A

    1. You have access
      Pharmacokinetics of zenarestat, an aldose reductase inhibitor, in male and female diabetic rats.
      Y Tanaka, T Sawamoto, A Suzuki and T Kimura
      Drug Metabolism and Disposition July 1993, 21 (4) 677-681;
  18. Swinney, D C

    1. You have access
      Cyclosporine metabolism by rat liver microsomes. Evidence for involvement of enzyme(s) other than cytochromes P-450 3A.
      T Prueksaritanont, M A Correia, A E Rettie, D C Swinney, P E Thomas and L Z Benet
      Drug Metabolism and Disposition July 1993, 21 (4) 730-737;

T

  1. Tanaka, Y

    1. You have access
      Pharmacokinetics of zenarestat, an aldose reductase inhibitor, in male and female diabetic rats.
      Y Tanaka, T Sawamoto, A Suzuki and T Kimura
      Drug Metabolism and Disposition July 1993, 21 (4) 677-681;
  2. Tani, M

    1. You have access
      The kinetic characterization of S-mephenytoin 4-hydroxylase (P-450IICMP) activity in human liver samples obtained as surgical waste from Japanese patients.
      K Chiba, K Kobayashi, M Tani, K Manabe and T Ishizaki
      Drug Metabolism and Disposition July 1993, 21 (4) 747-749;
  3. Tenney, K A

    1. You have access
      Pretranslational induction of CYP4A subfamily gene products in diabetic rats and reversal by oral vanadate treatment.
      N L Ferguson, B S Donahue, K A Tenney and E T Morgan
      Drug Metabolism and Disposition July 1993, 21 (4) 745-746;
  4. Thomas, P E

    1. You have access
      Cyclosporine metabolism by rat liver microsomes. Evidence for involvement of enzyme(s) other than cytochromes P-450 3A.
      T Prueksaritanont, M A Correia, A E Rettie, D C Swinney, P E Thomas and L Z Benet
      Drug Metabolism and Disposition July 1993, 21 (4) 730-737;

V

  1. Van Breemen, R B

    1. You have access
      Application of an immobilized digestive enzyme assay to measure chemical and enzymatic hydrolysis of the cyclic peptide antibiotic lysobactin.
      R K Blackburn and R B Van Breemen
      Drug Metabolism and Disposition July 1993, 21 (4) 573-579;
  2. Varga, S L

    1. You have access
      Biotransformation of 5-chloro-3-phenylthioindole-2-carboxamide (L-734,005) in rhesus monkeys and rat liver microsomes to a potent HIV-1 reverse transcriptase inhibitor.
      S K Balani, M E Goldman, L R Kauffman, S L Varga, J A O'Brien, S J Smith, T V Olah, H G Ramjit, T W Schorn and S M Pitzenberger
      Drug Metabolism and Disposition July 1993, 21 (4) 598-604;
  3. Venkataraman, P S

    1. You have access
      Redox cycling and hepatotoxicity of diquat in aging male Fischer 344 rats.
      L E Rikans, Y Cai, S D Kosanke and P S Venkataraman
      Drug Metabolism and Disposition July 1993, 21 (4) 605-610;
  4. Veyre, A

    1. You have access
      Biodistribution and metabolism of orally administered mitozolomide in mice.
      F Gachon, P Labarre, D Godeneche, M F Moreau, J Papon, J C Madelmont, A Veyre and G Gaillard
      Drug Metabolism and Disposition July 1993, 21 (4) 560-566;

W

  1. Wang, L

    1. You have access
      The disposition and renal handling of enprofylline in endotoxemic rats by bacterial lipopolysaccharide (LPS).
      M Nadai, T Hasegawa, K Kato, L Wang, T Nabeshima and N Kato
      Drug Metabolism and Disposition July 1993, 21 (4) 611-616;
  2. Washington, C B

    1. You have access
      Chemical, enzymatic, and human enantioselective S-oxygenation of cimetidine.
      J R Cashman, S B Park, Z C Yang, C B Washington, D Y Gomez, K M Giacomini and C M Brett
      Drug Metabolism and Disposition July 1993, 21 (4) 587-597;
  3. White, W R

    1. You have access
      Pharmacokinetics of methamphetamine self-administered to human subjects by smoking S-(+)-methamphetamine hydrochloride.
      C E Cook, A R Jeffcoat, J M Hill, D E Pugh, P K Patetta, B M Sadler, W R White and M Perez-Reyes
      Drug Metabolism and Disposition July 1993, 21 (4) 717-723;
  4. Wichmann, J K

    1. You have access
      Isolation and identification of 3-carbamoyloxy-2-phenylpropionic acid as a major human urinary metabolite of felbamate.
      V E Adusumalli, Y M Choi, L A Romanyshyn, R E Sparadoski, J K Wichmann, K K Wong, N Kucharczyk and R D Sofia
      Drug Metabolism and Disposition July 1993, 21 (4) 710-716;
  5. Wong, K K

    1. You have access
      Isolation and identification of 3-carbamoyloxy-2-phenylpropionic acid as a major human urinary metabolite of felbamate.
      V E Adusumalli, Y M Choi, L A Romanyshyn, R E Sparadoski, J K Wichmann, K K Wong, N Kucharczyk and R D Sofia
      Drug Metabolism and Disposition July 1993, 21 (4) 710-716;

Y

  1. Yang, Z C

    1. You have access
      Chemical, enzymatic, and human enantioselective S-oxygenation of cimetidine.
      J R Cashman, S B Park, Z C Yang, C B Washington, D Y Gomez, K M Giacomini and C M Brett
      Drug Metabolism and Disposition July 1993, 21 (4) 587-597;

Z

  1. Zimmerman, C L

    1. You have access
      Disposition of (-)carbovir in the in situ perfused rat liver and intestinal vasculature preparations.
      I Soria and C L Zimmerman
      Drug Metabolism and Disposition July 1993, 21 (4) 724-729;
Back to top
PreviousNext

In this issue

Drug Metabolism and Disposition
Vol. 21, Issue 4
1 Jul 1993
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • Cytochrome P450 inhibitors. Evaluation of specificities in the in vitrometabolism of therapeutic agents by human liver microsomes.
  • Prediction of Human Clearance of Twenty-Nine Drugs from Hepatic Microsomal Intrinsic Clearance Data: An Examination of In Vitro Half-Life Approach and Nonspecific Binding to Microsomes
  • DRUG-DRUG INTERACTIONS FOR UDP-GLUCURONOSYLTRANSFERASE SUBSTRATES: A PHARMACOKINETIC EXPLANATION FOR TYPICALLY OBSERVED LOW EXPOSURE (AUCI/AUC) RATIOS
  • In Vitro-In Vivo Scaling of CYP Kinetic Data Not Consistent with the Classical Michaelis-Menten Model
  • THE HUMAN INTESTINAL CYTOCHROME P450 “PIE”
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics